Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 2018

View Archived Issues

Sigilon Therapeutics' SIG-003 awarded EMA ATMP designation

iOx Therapeutics receives investment from Portage Biotech

Novel algorithm using proteotoxic biomarkers to discriminate between ASD and healthy subjects

Phase II data presented from the STOP-AKI trial of recAP in sepsis-associated acute kidney injury

Solifenacin oral suspension for pediatric patients approved in Europe

First-in-human results for Progenza in patients with knee osteoarthritis

Polyphor reports outcome of end-of-phase I meeting with FDA on balixafortide

Aradigm submits MAA for Linhaliq in non-cystic fibrosis bronchiectasis

CHRIST University patents new ER-targeting conjugates for cancer

Nanchang Helioeast Pharmaceutical presents new TKIs for cancer

Voyager Therapeutics reports longer-term data from phase Ib study of VY-AADC in Parkinson's disease

Biohaven restructures license agreement with Bristol-Myers Squibb

Medivir discloses novel compounds for RSV infection

IO Biotech collaborates with Merck & Co. to study IO-102 with pembrolizumab for NSCLC

Deinove enters antibiotic research collaboration with Naicons

FDA grants regenerative medicine advanced therapy designation to AmnioFix

BC-007 reduces autoantibodies against G-protein coupled receptors in phase I study

Seattle Genetics' acquisition of Cascadian Therapeutics complete

Kezar Life Sciences initiates phase I/II study of KZR-616 in SLE

Arrowhead opens enrollment in phase I study of ARO-AAT

Immutep and Merck & Co. to collaborate on phase II study of eftilagimod with pembrolizumab

CSL-112 found safe in patients with renal impairment after AMI

Diamyd Medical offers update from DIAGNODE-1 study of Diamyd diabetes vaccine

FDA awards fast track designation to NovaBiotics' Lynovex

Atrial fibrillation burden not reduced by XEN-D0103 in patients with pacemakers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...